David Genecov

Dialectic

Dialectic Therapeutics Plans to Further Cancer Drug Research Using $3M Seed Award

by | Feb 26, 2020
Using innovative new technologies and targeted therapies, the Dallas biotech startup aims to help patients with cancer, give them hope, and prolong their lives.
MORE
opioid
Richardson Startup Raises $4M, Moving Non-Opioid Drug Closer to Clinical Trial
by | Jul 27, 2017
A group of North Texas investors made up a major portion of the Series A round.
MORE